Gesundheit
Branchen-Index
Biotechnologie (Forschung)-Aktien
Vollständige Übersicht aller 397 börsennotierten Unternehmen der Branche Biotechnologie (Forschung). Vergleichen Sie Marktkapitalisierung, Bewertungs-KGV, Dividendenrendite und Insider-Scores im direkten Wettbewerbsvergleich.
Unternehmen
397
100 % erfasst
Gesamtkapitalisierung
3,15 Bio. $
Gesamtwert
Median-KGV
7,1
Bewertungsniveau
Ø Insider-Score
40,2
Conviction-Skala 0–100
| # | Unternehmen / Ticker | Marktkapitalisierung | Letzter Kurs | KGV | Dividende | Insider-Score | Analyse |
|---|---|---|---|---|---|---|---|
| 1 | BCAX Bicara Therapeutics Inc. | 1,27 Bio. $ Mega Cap | 23,64 $ | — | — | 33 | Details › |
| 2 | AKTX Akari Therapeutics Plc | 1,04 Bio. $ Mega Cap | 10,57 $ | — | — | 49 | Details › |
| 3 | TMO THERMO FISHER SCIENTIFIC INC. | 232,0 Mrd. $ Mega Cap | 605,69 $ | 34,0 | 0,3 % | 58 | Details › |
| 4 | LGVN Longeveron Inc. | 119,7 Mrd. $ Mega Cap | 6,58 $ | — | — | 19 | Details › |
| 5 | RVMD Revolution Medicines, Inc. | 41,4 Mrd. $ Mega Cap | 207,68 $ | — | — | 67 | Details › |
| 6 | ROIV Roivant Sciences Ltd. | 25,2 Mrd. $ Mega Cap | 41,81 $ | — | — | 37 | Details › |
| 7 | BNTX BioNTech SE | 24,9 Mrd. $ Mega Cap | 98,13 $ | — | — | 55 | Details › |
| 8 | GMAB GENMAB A/S | 20,7 Mrd. $ Mega Cap | 33,04 $ | — | — | 68 | Details › |
| 9 | BBIO BridgeBio Pharma, Inc. | 14,6 Mrd. $ Mega Cap | 76,08 $ | — | — | 44 | Details › |
| 10 | HALO HALOZYME THERAPEUTICS, INC. | 13,0 Mrd. $ Mega Cap | 107,39 $ | 42,3 | — | 50 | Details › |
| 11 | TECH BIO-TECHNE Corp | 11,3 Mrd. $ Mega Cap | 72,25 $ | 62,3 | 0,4 % | 47 | Details › |
| 12 | AXSM Axsome Therapeutics, Inc. | 10,5 Mrd. $ Mega Cap | 210,63 $ | — | — | 31 | Details › |
| 13 | KRYS Krystal Biotech, Inc. | 10,5 Mrd. $ Mega Cap | 348,09 $ | 51,4 | — | 58 | Details › |
| 14 | KYMR Kymera Therapeutics, Inc. | 9,5 Mrd. $ Large Cap | 115,43 $ | — | — | 49 | Details › |
| 15 | APGE Apogee Therapeutics, Inc. | 9,2 Mrd. $ Large Cap | 135,07 $ | — | — | 44 | Details › |
| 16 | PTGX Protagonist Therapeutics, Inc | 9,1 Mrd. $ Large Cap | 145,09 $ | — | — | 60 | Details › |
| 17 | PRAX Praxis Precision Medicines, Inc. | 8,9 Mrd. $ Large Cap | 345,30 $ | — | — | 30 | Details › |
| 18 | IBRX ImmunityBio, Inc. | 8,2 Mrd. $ Large Cap | 8,06 $ | — | — | 47 | Details › |
| 19 | PCVX Vaxcyte, Inc. | 8,0 Mrd. $ Large Cap | 59,51 $ | — | — | 44 | Details › |
| 20 | TWST Twist Bioscience Corp | 7,6 Mrd. $ Large Cap | 125,52 $ | — | — | 46 | Details › |
| 21 | SYRE Spyre Therapeutics, Inc. | 7,0 Mrd. $ Large Cap | 86,93 $ | — | — | 44 | Details › |
| 22 | CGON CG Oncology, Inc. | 6,0 Mrd. $ Large Cap | 71,96 $ | — | — | 34 | Details › |
| 23 | SRRK Scholar Rock Holding Corp | 6,0 Mrd. $ Large Cap | 54,62 $ | — | — | 38 | Details › |
| 24 | COGT Cogent Biosciences, Inc. | 5,6 Mrd. $ Large Cap | 34,18 $ | — | — | 49 | Details › |
| 25 | CRSP CRISPR Therapeutics AG | 5,3 Mrd. $ Large Cap | 53,45 $ | — | — | 45 | Details › |
| 26 | XENE Xenon Pharmaceuticals Inc. | 4,8 Mrd. $ Large Cap | 58,98 $ | — | — | 47 | Details › |
| 27 | DNTH Dianthus Therapeutics, Inc. /DE/ | 4,7 Mrd. $ Large Cap | 107,04 $ | — | — | 54 | Details › |
| 28 | CELC Celcuity Inc. | 4,6 Mrd. $ Large Cap | 90,08 $ | — | — | 41 | Details › |
| 29 | EWTX Edgewise Therapeutics, Inc. | 4,6 Mrd. $ Large Cap | 43,39 $ | — | — | 51 | Details › |
| 30 | ORKA Oruka Therapeutics, Inc. | 4,5 Mrd. $ Large Cap | 91,50 $ | — | — | 40 | Details › |
| 31 | DYN Dyne Therapeutics, Inc. | 4,0 Mrd. $ Large Cap | 19,19 $ | — | — | 36 | Details › |
| 32 | VKTX Viking Therapeutics, Inc. | 4,0 Mrd. $ Large Cap | 32,70 $ | — | — | 40 | Details › |
| 33 | LEGN Legend Biotech Corp | 3,8 Mrd. $ Large Cap | 19,91 $ | — | — | 46 | Details › |
| 34 | RCUS Arcus Biosciences, Inc. | 3,7 Mrd. $ Large Cap | 28,49 $ | — | — | 30 | Details › |
| 35 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | 3,6 Mrd. $ Large Cap | 8,43 $ | — | — | 34 | Details › |
| 36 | ELVN Enliven Therapeutics, Inc. | 3,5 Mrd. $ Large Cap | 57,45 $ | — | — | 57 | Details › |
| 37 | IDYA IDEAYA Biosciences, Inc. | 3,5 Mrd. $ Large Cap | 38,35 $ | — | — | 52 | Details › |
| 38 | DNLI Denali Therapeutics Inc. | 3,5 Mrd. $ Large Cap | 21,57 $ | — | — | 48 | Details › |
| 39 | ABCL AbCellera Biologics Inc. | 3,4 Mrd. $ Large Cap | 11,05 $ | — | — | 10 | Details › |
| 40 | RLAY Relay Therapeutics, Inc. | 3,3 Mrd. $ Large Cap | 18,66 $ | — | — | 37 | Details › |
| 41 | TNGX Tango Therapeutics, Inc. | 3,1 Mrd. $ Large Cap | 24,00 $ | — | — | 29 | Details › |
| 42 | BEAM Beam Therapeutics Inc. | 3,0 Mrd. $ Large Cap | 25,18 $ | — | — | 32 | Details › |
| 43 | IRON Disc Medicine, Inc. | 3,0 Mrd. $ Large Cap | 76,51 $ | — | — | 49 | Details › |
| 44 | RGC Regencell Bioscience Holdings Ltd | 2,9 Mrd. $ Large Cap | 5,85 $ | — | — | 40 | Details › |
| 45 | MBX MBX Biosciences, Inc. | 2,8 Mrd. $ Large Cap | 62,18 $ | — | — | 42 | Details › |
| 46 | QURE uniQure N.V. | 2,8 Mrd. $ Large Cap | 46,00 $ | — | — | 45 | Details › |
| 47 | NRIX Nurix Therapeutics, Inc. | 2,7 Mrd. $ Large Cap | 26,26 $ | — | — | 36 | Details › |
| 48 | CLDX Celldex Therapeutics, Inc. | 2,6 Mrd. $ Large Cap | 38,78 $ | — | — | 47 | Details › |
| 49 | PGEN PRECIGEN, INC. | 2,5 Mrd. $ Large Cap | 6,80 $ | — | — | 30 | Details › |
| 50 | VRDN Viridian Therapeutics, Inc.\DE | 2,3 Mrd. $ Large Cap | 22,73 $ | — | — | 32 | Details › |
| 51 | VERA Vera Therapeutics, Inc. | 2,3 Mrd. $ Large Cap | 33,78 $ | — | — | 39 | Details › |
| 52 | NUVB Nuvation Bio Inc. | 2,3 Mrd. $ Large Cap | 6,52 $ | — | — | 40 | Details › |
| 53 | MLYS Mineralys Therapeutics, Inc. | 2,3 Mrd. $ Large Cap | 30,50 $ | — | — | 40 | Details › |
| 54 | RAPP Rapport Therapeutics, Inc. | 2,2 Mrd. $ Large Cap | 43,89 $ | — | — | 35 | Details › |
| 55 | KOD Kodiak Sciences Inc. | 2,2 Mrd. $ Large Cap | 33,78 $ | — | — | 46 | Details › |
| 56 | ZYME Zymeworks Inc. | 2,2 Mrd. $ Large Cap | 27,15 $ | — | — | 38 | Details › |
| 57 | MESO MESOBLAST LTD | 2,1 Mrd. $ Large Cap | 16,14 $ | — | — | 37 | Details › |
| 58 | SLS SELLAS Life Sciences Group, Inc. | 2,1 Mrd. $ Large Cap | 13,95 $ | — | — | 33 | Details › |
| 59 | BHVN Biohaven Ltd. | 2,1 Mrd. $ Large Cap | 15,00 $ | — | — | 46 | Details › |
| 60 | COAG Hemab Therapeutics Holdings, Inc. | 2,1 Mrd. $ Large Cap | 44,50 $ | — | — | 29 | Details › |
| 61 | SLN Silence Therapeutics plc | 2,1 Mrd. $ Large Cap | 13,55 $ | — | — | 50 | Details › |
| 62 | VCEL Vericel Corp | 2,0 Mrd. $ Large Cap | 38,99 $ | 122,1 | — | 63 | Details › |
| 63 | GENB Generate Biomedicines, Inc. | 2,0 Mrd. $ Large Cap | 15,52 $ | — | — | 25 | Details › |
| 64 | GHRS GH Research PLC | 1,9 Mrd. $ Mid Cap | 27,56 $ | — | — | 40 | Details › |
| 65 | RXRX RECURSION PHARMACEUTICALS, INC. | 1,9 Mrd. $ Mid Cap | 3,22 $ | — | — | 23 | Details › |
| 66 | XNCR Xencor Inc | 1,9 Mrd. $ Mid Cap | 24,94 $ | — | — | 35 | Details › |
| 67 | GLPG Lakefront Biotherapeutics NV | 1,8 Mrd. $ Mid Cap | 27,93 $ | — | — | — | Details › |
| 68 | IMCR Immunocore Holdings plc | 1,8 Mrd. $ Mid Cap | 34,47 $ | — | — | 35 | Details › |
| 69 | ZBIO Zenas BioPharma, Inc. | 1,8 Mrd. $ Mid Cap | 31,09 $ | — | — | 24 | Details › |
| 70 | INBX Inhibrx Biosciences, Inc. | 1,8 Mrd. $ Mid Cap | 112,86 $ | — | — | 42 | Details › |
| 71 | SCNI Scinai Immunotherapeutics Ltd. | 1,7 Mrd. $ Mid Cap | 1,71 $ | — | — | — | Details › |
| 72 | FTRE Fortrea Holdings Inc. | 1,6 Mrd. $ Mid Cap | 16,79 $ | — | — | 53 | Details › |
| 73 | SEPN Septerna, Inc. | 1,6 Mrd. $ Mid Cap | 37,97 $ | — | — | 46 | Details › |
| 74 | TSHA Taysha Gene Therapies, Inc. | 1,6 Mrd. $ Mid Cap | 5,34 $ | — | — | 46 | Details › |
| 75 | ANAB ANAPTYSBIO, INC | 1,6 Mrd. $ Mid Cap | 55,70 $ | — | — | 49 | Details › |
| 76 | VIR Vir Biotechnology, Inc. | 1,6 Mrd. $ Mid Cap | 10,81 $ | — | — | 25 | Details › |
| 77 | TYRA Tyra Biosciences, Inc. | 1,5 Mrd. $ Mid Cap | 22,01 $ | — | — | 31 | Details › |
| 78 | NKTR NEKTAR THERAPEUTICS | 1,5 Mrd. $ Mid Cap | 73,32 $ | — | — | 36 | Details › |
| 79 | TRAX First Tracks Biotherapeutics, Inc. | 1,5 Mrd. $ Mid Cap | 39,57 $ | — | — | 46 | Details › |
| 80 | NTLA Intellia Therapeutics, Inc. | 1,5 Mrd. $ Mid Cap | 12,21 $ | — | — | 46 | Details › |
| 81 | SLBT SL Science Holding Ltd | 1,5 Mrd. $ Mid Cap | 2,61 $ | — | — | 29 | Details › |
| 82 | AZTA Azenta, Inc. | 1,4 Mrd. $ Mid Cap | 30,15 $ | — | 0,3 % | 45 | Details › |
| 83 | DBVT DBV Technologies S.A. | 1,4 Mrd. $ Mid Cap | 13,44 $ | — | — | 30 | Details › |
| 84 | OMER OMEROS CORP | 1,4 Mrd. $ Mid Cap | 19,39 $ | — | — | 24 | Details › |
| 85 | ODTX Odyssey Therapeutics, Inc. | 1,3 Mrd. $ Mid Cap | 24,51 $ | — | — | — | Details › |
| 86 | AKTS Aktis Oncology, Inc. | 1,3 Mrd. $ Mid Cap | 24,06 $ | — | — | 47 | Details › |
| 87 | MAZE Maze Therapeutics, Inc. | 1,3 Mrd. $ Mid Cap | 25,13 $ | — | — | 65 | Details › |
| 88 | CMPS COMPASS Pathways plc | 1,3 Mrd. $ Mid Cap | 15,17 $ | — | — | 38 | Details › |
| 89 | ORIC Oric Pharmaceuticals, Inc. | 1,3 Mrd. $ Mid Cap | 12,50 $ | — | — | 19 | Details › |
| 90 | IMTX Immatics N.V. | 1,3 Mrd. $ Mid Cap | 9,11 $ | — | — | 55 | Details › |
| 91 | REPL Replimune Group, Inc. | 1,2 Mrd. $ Mid Cap | 14,45 $ | — | — | 22 | Details › |
| 92 | JANX Janux Therapeutics, Inc. | 1,2 Mrd. $ Mid Cap | 19,33 $ | — | — | 39 | Details › |
| 93 | LBRX LB PHARMACEUTICALS INC | 1,2 Mrd. $ Mid Cap | 46,05 $ | — | — | 46 | Details › |
| 94 | IMUX IMMUNIC, INC. | 1,2 Mrd. $ Mid Cap | 12,19 $ | — | — | 27 | Details › |
| 95 | MGTX MeiraGTx Holdings plc | 1,1 Mrd. $ Mid Cap | 13,26 $ | — | — | 26 | Details › |
| 96 | SLXN Silexion Therapeutics Corp | 1,1 Mrd. $ Mid Cap | 0,35 $ | 0,0 | — | — | Details › |
| 97 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | 1,1 Mrd. $ Mid Cap | 6,95 $ | — | — | 48 | Details › |
| 98 | SANA Sana Biotechnology, Inc. | 1,0 Mrd. $ Mid Cap | 3,17 $ | — | — | 40 | Details › |
| 99 | ABSI Absci Corp | 1,0 Mrd. $ Mid Cap | 8,65 $ | — | — | 25 | Details › |
| 100 | ABUS Arbutus Biopharma Corp | 991,5 Mio. $ Mid Cap | 5,17 $ | — | — | 42 | Details › |
| 101 | JBIO Jade Biosciences, Inc. | 981,4 Mio. $ Mid Cap | 19,06 $ | — | — | 34 | Details › |
| 102 | VOR Vor Biopharma Inc. | 969,9 Mio. $ Mid Cap | 23,24 $ | — | — | 36 | Details › |
| 103 | ARDX ARDELYX, INC. | 923,6 Mio. $ Mid Cap | 3,80 $ | — | — | 41 | Details › |
| 104 | DSGN Design Therapeutics, Inc. | 914,4 Mio. $ Mid Cap | 15,02 $ | — | — | 45 | Details › |
| 105 | ALMS ALUMIS INC. | 895,4 Mio. $ Mid Cap | 9,89 $ | — | — | 53 | Details › |
| 106 | RIGL RIGEL PHARMACEUTICALS INC | 891,2 Mio. $ Mid Cap | 47,22 $ | 2,4 | — | 56 | Details › |
| 107 | OLMA Olema Pharmaceuticals, Inc. | 874,8 Mio. $ Mid Cap | 10,36 $ | — | — | 51 | Details › |
| 108 | FDMT 4D Molecular Therapeutics, Inc. | 862,4 Mio. $ Mid Cap | 14,18 $ | — | — | 37 | Details › |
| 109 | ANL Adlai Nortye Group Ltd. | 843,4 Mio. $ Mid Cap | 14,70 $ | — | — | 28 | Details › |
| 110 | SLDB Solid Biosciences Inc. | 809,4 Mio. $ Mid Cap | 9,54 $ | — | — | 29 | Details › |
| 111 | MLTX MoonLake Immunotherapeutics | 791,0 Mio. $ Mid Cap | 13,72 $ | — | — | 38 | Details › |
| 112 | MNPR Monopar Therapeutics | 786,7 Mio. $ Mid Cap | 112,38 $ | — | — | 32 | Details › |
| 113 | CLYM Climb Bio, Inc. | 757,8 Mio. $ Mid Cap | 14,20 $ | — | — | 45 | Details › |
| 114 | ACRS Aclaris Therapeutics, Inc. | 743,5 Mio. $ Mid Cap | 5,56 $ | — | — | 38 | Details › |
| 115 | IMMX Immix Biopharma, Inc. | 736,5 Mio. $ Mid Cap | 12,31 $ | — | — | 33 | Details › |
| 116 | AGMB Agomab Therapeutics NV | 727,9 Mio. $ Mid Cap | 14,96 $ | — | — | 61 | Details › |
| 117 | CADL Candel Therapeutics, Inc. | 701,6 Mio. $ Mid Cap | 12,17 $ | — | — | 38 | Details › |
| 118 | PHAT Phathom Pharmaceuticals, Inc. | 678,5 Mio. $ Mid Cap | 8,67 $ | — | — | 30 | Details › |
| 119 | PRME Prime Medicine, Inc. | 667,9 Mio. $ Mid Cap | 3,47 $ | — | — | 35 | Details › |
| 120 | VALN Valneva SE | 660,9 Mio. $ Mid Cap | 6,68 $ | — | — | 29 | Details › |
| 121 | DRUG BRIGHT MINDS BIOSCIENCES INC. | 652,8 Mio. $ Mid Cap | 65,06 $ | — | — | 47 | Details › |
| 122 | EVO Evotec SE | 643,0 Mio. $ Mid Cap | 1,86 $ | — | — | — | Details › |
| 123 | CTMX CytomX Therapeutics, Inc. | 631,4 Mio. $ Mid Cap | 3,54 $ | — | — | 57 | Details › |
| 124 | OABI OmniAb, Inc. | 624,9 Mio. $ Mid Cap | 4,01 $ | — | 59,0 % | 57 | Details › |
| 125 | NGNE Neurogene Inc. | 597,9 Mio. $ Mid Cap | 37,88 $ | — | — | 59 | Details › |
| 126 | MPLT MapLight Therapeutics, Inc. | 597,8 Mio. $ Mid Cap | 13,54 $ | — | — | 31 | Details › |
| 127 | ARVN ARVINAS, INC. | 596,3 Mio. $ Mid Cap | 8,76 $ | — | — | 51 | Details › |
| 128 | AUTL Autolus Therapeutics plc | 596,1 Mio. $ Mid Cap | 2,03 $ | — | — | 28 | Details › |
| 129 | EIKN Eikon Therapeutics, Inc. | 590,1 Mio. $ Mid Cap | 9,92 $ | — | — | 33 | Details › |
| 130 | ASMB ASSEMBLY BIOSCIENCES, INC. | 580,3 Mio. $ Mid Cap | 32,87 $ | — | — | 58 | Details › |
| 131 | TECX Tectonic Therapeutic, Inc. | 576,2 Mio. $ Mid Cap | 30,48 $ | — | — | 27 | Details › |
| 132 | CBIO CRESCENT BIOPHARMA, INC. | 575,4 Mio. $ Mid Cap | 19,99 $ | — | — | 39 | Details › |
| 133 | CAPR CAPRICOR THERAPEUTICS, INC. | 539,3 Mio. $ Mid Cap | 8,64 $ | — | — | -3 | Details › |
| 134 | PRTA PROTHENA CORP PUBLIC LTD CO | 528,6 Mio. $ Mid Cap | 9,30 $ | — | — | 42 | Details › |
| 135 | KYTX Kyverna Therapeutics, Inc. | 498,2 Mio. $ Mid Cap | 7,64 $ | — | — | 33 | Details › |
| 136 | PBYI PUMA BIOTECHNOLOGY, INC. | 481,4 Mio. $ Mid Cap | 9,05 $ | 15,4 | — | 62 | Details › |
| 137 | AURA Aura Biosciences, Inc. | 480,7 Mio. $ Mid Cap | 7,20 $ | — | — | 41 | Details › |
| 138 | CTNM Contineum Therapeutics, Inc. | 462,6 Mio. $ Mid Cap | 15,14 $ | — | — | 59 | Details › |
| 139 | ZURA Zura Bio Ltd | 459,0 Mio. $ Mid Cap | 5,71 $ | — | — | 46 | Details › |
| 140 | RGNX REGENXBIO Inc. | 455,0 Mio. $ Mid Cap | 8,73 $ | — | — | 8 | Details › |
| 141 | ALLO Allogene Therapeutics, Inc. | 451,9 Mio. $ Mid Cap | 1,73 $ | — | — | 55 | Details › |
| 142 | ARCT Arcturus Therapeutics Holdings Inc. | 449,5 Mio. $ Mid Cap | 14,74 $ | — | — | 20 | Details › |
| 143 | STTK Shattuck Labs, Inc. | 429,7 Mio. $ Mid Cap | 6,33 $ | — | — | 43 | Details › |
| 144 | OCGN Ocugen, Inc. | 424,8 Mio. $ Mid Cap | 1,07 $ | — | — | 36 | Details › |
| 145 | CMPX Compass Therapeutics, Inc. | 424,4 Mio. $ Mid Cap | 2,18 $ | — | — | 35 | Details › |
| 146 | LNAI Lunai Bioworks Inc. | 424,0 Mio. $ Mid Cap | 2,61 $ | — | — | — | Details › |
| 147 | PRLD Prelude Therapeutics Inc | 420,2 Mio. $ Mid Cap | 5,09 $ | — | — | 44 | Details › |
| 148 | RCKT ROCKET PHARMACEUTICALS, INC. | 418,1 Mio. $ Mid Cap | 3,63 $ | — | — | 56 | Details › |
| 149 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 407,6 Mio. $ Mid Cap | 1,29 $ | — | — | 24 | Details › |
| 150 | DNA Ginkgo Bioworks Holdings, Inc. | 404,5 Mio. $ Mid Cap | 6,79 $ | — | — | 32 | Details › |
| 151 | EVMN Evommune, Inc. | 386,8 Mio. $ Mid Cap | 10,84 $ | — | — | 27 | Details › |
| 152 | ALT Altimmune, Inc. | 379,2 Mio. $ Mid Cap | 3,35 $ | — | — | 43 | Details › |
| 153 | TKNO Alpha Teknova, Inc. | 370,7 Mio. $ Mid Cap | 6,96 $ | — | — | 43 | Details › |
| 154 | OVID Ovid Therapeutics Inc. | 364,5 Mio. $ Mid Cap | 2,70 $ | — | — | 34 | Details › |
| 155 | CCCC C4 Therapeutics, Inc. | 364,4 Mio. $ Mid Cap | 3,44 $ | — | — | 54 | Details › |
| 156 | DMAC DiaMedica Therapeutics Inc. | 362,8 Mio. $ Mid Cap | 6,59 $ | — | — | 47 | Details › |
| 157 | BIOA BioAge Labs, Inc. | 357,4 Mio. $ Mid Cap | 8,89 $ | — | — | 48 | Details › |
| 158 | LXEO Lexeo Therapeutics, Inc. | 357,0 Mio. $ Mid Cap | 4,48 $ | — | — | 39 | Details › |
| 159 | AVTX Avalo Therapeutics, Inc. | 356,0 Mio. $ Mid Cap | 18,21 $ | — | — | 33 | Details › |
| 160 | SGMT Sagimet Biosciences Inc. | 353,9 Mio. $ Mid Cap | 10,86 $ | — | — | 33 | Details › |
| 161 | CABA Cabaletta Bio, Inc. | 348,7 Mio. $ Mid Cap | 2,91 $ | — | — | 48 | Details › |
| 162 | GRML Greenland Mines Ltd | 336,6 Mio. $ Mid Cap | 3,85 $ | — | 429,0 % | 28 | Details › |
| 163 | PALI PALISADE BIO, INC. | 333,2 Mio. $ Mid Cap | 2,05 $ | — | — | 47 | Details › |
| 164 | BNTC Benitec Biopharma Inc. | 332,9 Mio. $ Mid Cap | 12,45 $ | — | — | 43 | Details › |
| 165 | ABEO ABEONA THERAPEUTICS INC. | 330,3 Mio. $ Mid Cap | 5,79 $ | 5,8 | — | 48 | Details › |
| 166 | IKT Inhibikase Therapeutics, Inc. | 329,2 Mio. $ Mid Cap | 2,41 $ | — | — | 42 | Details › |
| 167 | UPB Upstream Bio, Inc. | 326,0 Mio. $ Mid Cap | 5,96 $ | — | — | 44 | Details › |
| 168 | RLMD RELMADA THERAPEUTICS, INC. | 324,9 Mio. $ Mid Cap | 4,09 $ | — | — | 52 | Details › |
| 169 | SION Sionna Therapeutics, Inc. | 321,1 Mio. $ Mid Cap | 7,48 $ | — | — | 58 | Details › |
| 170 | LRMR Larimar Therapeutics, Inc. | 318,2 Mio. $ Mid Cap | 3,87 $ | — | — | 52 | Details › |
| 171 | EDIT Editas Medicine, Inc. | 316,1 Mio. $ Mid Cap | 2,77 $ | — | — | 54 | Details › |
| 172 | CLLS Cellectis S.A. | 309,3 Mio. $ Mid Cap | 3,40 $ | — | — | — | Details › |
| 173 | LYEL Lyell Immunopharma, Inc. | 305,4 Mio. $ Mid Cap | 12,88 $ | — | — | 37 | Details › |
| 174 | ENTA ENANTA PHARMACEUTICALS INC | 301,1 Mio. $ Mid Cap | 13,24 $ | — | — | 54 | Details › |
| 175 | GALT GALECTIN THERAPEUTICS INC | 300,6 Mio. $ Mid Cap | 4,05 $ | — | — | 44 | Details › |
| 176 | BCYC BICYCLE THERAPEUTICS PLC | 298,3 Mio. $ Small Cap | 4,01 $ | — | — | 62 | Details › |
| 177 | AGEN AGENUS INC | 291,0 Mio. $ Small Cap | 6,86 $ | — | — | 27 | Details › |
| 178 | FATE FATE THERAPEUTICS INC | 286,1 Mio. $ Small Cap | 2,44 $ | — | — | 46 | Details › |
| 179 | ACIU AC Immune SA | 282,9 Mio. $ Small Cap | 2,76 $ | — | — | 45 | Details › |
| 180 | EPRX EUPRAXIA PHARMACEUTICALS INC. | 279,2 Mio. $ Small Cap | 8,08 $ | — | — | 48 | Details › |
| 181 | FHTX Foghorn Therapeutics Inc. | 278,8 Mio. $ Small Cap | 4,67 $ | — | — | 50 | Details › |
| 182 | LEXX Lexaria Bioscience Corp. | 276,8 Mio. $ Small Cap | 6,60 $ | — | — | 41 | Details › |
| 183 | CYDY CytoDyn Inc. | 273,7 Mio. $ Small Cap | 0,20 $ | — | — | 21 | Details › |
| 184 | TRDA Entrada Therapeutics, Inc. | 273,0 Mio. $ Small Cap | 7,11 $ | — | — | 47 | Details › |
| 185 | ARTV Artiva Biotherapeutics, Inc. | 269,1 Mio. $ Small Cap | 10,87 $ | — | — | 40 | Details › |
| 186 | YDES YD Bio Ltd | 268,5 Mio. $ Small Cap | 3,93 $ | — | — | 50 | Details › |
| 187 | LAB STANDARD BIOTOOLS INC. | 264,9 Mio. $ Small Cap | 0,73 $ | — | — | 46 | Details › |
| 188 | NWBO NORTHWEST BIOTHERAPEUTICS INC | 264,4 Mio. $ Small Cap | 0,17 $ | — | — | 30 | Details › |
| 189 | LCTX Lineage Cell Therapeutics, Inc. | 262,6 Mio. $ Small Cap | 1,03 $ | — | — | 60 | Details › |
| 190 | NAGE Niagen Bioscience, Inc. | 252,7 Mio. $ Small Cap | 3,05 $ | 15,5 | — | 52 | Details › |
| 191 | BCDA BioCardia, Inc. | 248,7 Mio. $ Small Cap | 1,10 $ | — | — | 43 | Details › |
| 192 | AVXL ANAVEX LIFE SCIENCES CORP. | 247,9 Mio. $ Small Cap | 2,75 $ | — | — | 54 | Details › |
| 193 | CGEN COMPUGEN LTD | 245,4 Mio. $ Small Cap | 2,48 $ | — | — | 40 | Details › |
| 194 | PYXS Pyxis Oncology, Inc. | 243,9 Mio. $ Small Cap | 3,38 $ | — | — | 39 | Details › |
| 195 | IVA Inventiva S.A. | 242,2 Mio. $ Small Cap | 4,45 $ | — | — | 40 | Details › |
| 196 | RNAC Cartesian Therapeutics, Inc. | 241,1 Mio. $ Small Cap | 8,69 $ | — | — | 47 | Details › |
| 197 | IMA ImageneBio, Inc. | 234,1 Mio. $ Small Cap | 5,01 $ | — | — | — | Details › |
| 198 | SCYX SCYNEXIS INC | 230,8 Mio. $ Small Cap | 4,91 $ | — | — | 47 | Details › |
| 199 | NMRA Neumora Therapeutics, Inc. | 228,3 Mio. $ Small Cap | 1,20 $ | — | — | 42 | Details › |
| 200 | CAMP Camp4 Therapeutics Corp | 227,2 Mio. $ Small Cap | 4,27 $ | — | — | 27 | Details › |
| 201 | VRXA Veraxa Biotech AG - Post de-SPAC | 223,4 Mio. $ Small Cap | 1,64 $ | — | — | 90 | Details › |
| 202 | SRZN Surrozen, Inc./DE | 222,5 Mio. $ Small Cap | 20,03 $ | — | — | 43 | Details › |
| 203 | KROS Keros Therapeutics, Inc. | 221,2 Mio. $ Small Cap | 11,31 $ | 4,9 | — | 52 | Details › |
| 204 | PRQR ProQR Therapeutics N.V. | 216,9 Mio. $ Small Cap | 1,99 $ | — | — | 45 | Details › |
| 205 | WHWK Whitehawk Therapeutics, Inc. | 216,9 Mio. $ Small Cap | 4,19 $ | — | — | 53 | Details › |
| 206 | PEPG PepGen Inc. | 214,2 Mio. $ Small Cap | 3,15 $ | — | — | 37 | Details › |
| 207 | ARMP Armata Pharmaceuticals, Inc. | 212,8 Mio. $ Small Cap | 5,41 $ | — | — | 48 | Details › |
| 208 | IMRX Immuneering Corp | 212,1 Mio. $ Small Cap | 4,61 $ | — | — | 38 | Details › |
| 209 | TARA Protara Therapeutics, Inc. | 211,1 Mio. $ Small Cap | 3,83 $ | — | — | 51 | Details › |
| 210 | NBP NovaBridge Biosciences | 208,6 Mio. $ Small Cap | 1,70 $ | — | — | 59 | Details › |
| 211 | NKTX Nkarta, Inc. | 207,5 Mio. $ Small Cap | 2,91 $ | — | — | 39 | Details › |
| 212 | VYGR Voyager Therapeutics, Inc. | 207,3 Mio. $ Small Cap | 3,25 $ | — | — | 39 | Details › |
| 213 | CYPH CYPHERPUNK TECHNOLOGIES INC. | 202,9 Mio. $ Small Cap | 2,45 $ | 37,6 | — | 34 | Details › |
| 214 | ORMP ORAMED PHARMACEUTICALS INC. | 196,8 Mio. $ Small Cap | 4,78 $ | 3,3 | 5,0 % | 71 | Details › |
| 215 | CRBP Corbus Pharmaceuticals Holdings, Inc. | 195,1 Mio. $ Small Cap | 8,86 $ | — | — | 48 | Details › |
| 216 | RNA Atrium Therapeutics, Inc. | 194,3 Mio. $ Small Cap | 10,51 $ | — | — | 48 | Details › |
| 217 | ABOS Acumen Pharmaceuticals, Inc. | 192,6 Mio. $ Small Cap | 2,85 $ | — | — | 71 | Details › |
| 218 | IPHA Innate Pharma SA | 186,9 Mio. $ Small Cap | 2,17 $ | — | — | — | Details › |
| 219 | IPSC Century Therapeutics, Inc. | 184,7 Mio. $ Small Cap | 2,03 $ | — | — | 39 | Details › |
| 220 | DTIL PRECISION BIOSCIENCES INC | 179,9 Mio. $ Small Cap | 7,25 $ | — | — | 37 | Details › |
| 221 | SABS SAB Biotherapeutics, Inc. | 177,1 Mio. $ Small Cap | 3,48 $ | — | — | 48 | Details › |
| 222 | STRO SUTRO BIOPHARMA, INC. | 172,3 Mio. $ Small Cap | 18,36 $ | — | — | 38 | Details › |
| 223 | ADCT ADC Therapeutics SA | 171,0 Mio. $ Small Cap | 1,22 $ | — | — | 21 | Details › |
| 224 | RANI Rani Therapeutics Holdings, Inc. | 162,0 Mio. $ Small Cap | 0,84 $ | — | — | 39 | Details › |
| 225 | QTTB Q32 Bio Inc. | 154,2 Mio. $ Small Cap | 11,14 $ | 4,8 | — | 40 | Details › |
| 226 | QSI Quantum-Si Inc | 151,5 Mio. $ Small Cap | 0,75 $ | — | — | 34 | Details › |
| 227 | CRBU Caribou Biosciences, Inc. | 149,4 Mio. $ Small Cap | 1,44 $ | — | — | 44 | Details › |
| 228 | TNYA Tenaya Therapeutics, Inc. | 148,1 Mio. $ Small Cap | 0,66 $ | — | — | 49 | Details › |
| 229 | CURX Curanex Pharmaceuticals Inc | 142,8 Mio. $ Small Cap | 4,20 $ | — | — | — | Details › |
| 230 | INDP Indaptus Therapeutics, Inc. | 141,7 Mio. $ Small Cap | 2,08 $ | — | — | 13 | Details › |
| 231 | MXCT MAXCYTE, INC. | 136,7 Mio. $ Small Cap | 1,22 $ | — | — | 57 | Details › |
| 232 | EQ Equillium, Inc. | 135,8 Mio. $ Small Cap | 2,56 $ | — | — | 51 | Details › |
| 233 | ADAG Adagene Inc. | 132,1 Mio. $ Small Cap | 3,27 $ | — | — | 48 | Details › |
| 234 | CDXS CODEXIS, INC. | 132,1 Mio. $ Small Cap | 1,43 $ | — | — | 47 | Details › |
| 235 | HURA TuHURA Biosciences, Inc./NV | 127,0 Mio. $ Small Cap | 2,01 $ | — | — | 48 | Details › |
| 236 | PROK PROKIDNEY CORP. | 123,7 Mio. $ Small Cap | 1,85 $ | — | — | 29 | Details › |
| 237 | SEER Seer, Inc. | 123,7 Mio. $ Small Cap | 1,94 $ | — | — | 54 | Details › |
| 238 | BDTX Black Diamond Therapeutics, Inc. | 121,1 Mio. $ Small Cap | 2,10 $ | 5,4 | — | 58 | Details › |
| 239 | OKUR OnKure Therapeutics, Inc. | 119,6 Mio. $ Small Cap | 3,38 $ | — | — | 56 | Details › |
| 240 | VXRT Vaxart, Inc. | 119,0 Mio. $ Small Cap | 0,49 $ | 7,1 | — | 50 | Details › |
| 241 | KRRO Korro Bio, Inc. | 115,3 Mio. $ Small Cap | 12,93 $ | — | — | 35 | Details › |
| 242 | NAUT Nautilus Biotechnology, Inc. | 114,4 Mio. $ Small Cap | 1,12 $ | — | — | 60 | Details › |
| 243 | UNCY Unicycive Therapeutics, Inc. | 114,1 Mio. $ Small Cap | 5,12 $ | — | — | 34 | Details › |
| 244 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | 110,6 Mio. $ Small Cap | 3,62 $ | — | — | 31 | Details › |
| 245 | ALXO ALX ONCOLOGY HOLDINGS INC | 109,3 Mio. $ Small Cap | 1,84 $ | — | — | 68 | Details › |
| 246 | GUTS FRACTYL HEALTH, INC. | 106,8 Mio. $ Small Cap | 0,64 $ | — | — | 22 | Details › |
| 247 | ANIX Anixa Biosciences Inc | 101,4 Mio. $ Small Cap | 2,83 $ | — | — | 35 | Details › |
| 248 | PYPD PolyPid Ltd. | 101,3 Mio. $ Small Cap | 5,20 $ | — | — | 48 | Details › |
| 249 | CMMB Chemomab Therapeutics Ltd. | 100,5 Mio. $ Small Cap | 2,69 $ | 22,7 | — | — | Details › |
| 250 | LIMN Liminatus Pharma, Inc. | 100,4 Mio. $ Small Cap | 3,48 $ | — | — | — | Details › |
| 251 | COYA Coya Therapeutics, Inc. | 99,6 Mio. $ Small Cap | 4,61 $ | — | — | 47 | Details › |
| 252 | INO INOVIO PHARMACEUTICALS, INC. | 98,7 Mio. $ Small Cap | 1,32 $ | — | — | 18 | Details › |
| 253 | PLYX Polaryx Therapeutics, Inc. | 94,7 Mio. $ Small Cap | 2,08 $ | — | — | 37 | Details › |
| 254 | ENGN enGene Therapeutics Inc. | 94,7 Mio. $ Small Cap | 1,85 $ | 0,8 | — | 36 | Details › |
| 255 | GNLX GENELUX Corp | 93,1 Mio. $ Small Cap | 2,52 $ | — | — | 53 | Details › |
| 256 | ACET Adicet Bio, Inc. | 91,9 Mio. $ Small Cap | 9,54 $ | — | — | 45 | Details › |
| 257 | CGTX COGNITION THERAPEUTICS INC | 91,6 Mio. $ Small Cap | 0,99 $ | — | — | 41 | Details › |
| 258 | ONCY ONCOLYTICS BIOTECH INC | 91,1 Mio. $ Small Cap | 0,80 $ | — | — | 43 | Details › |
| 259 | RLYB Rallybio Corp | 89,4 Mio. $ Small Cap | 16,97 $ | — | — | 61 | Details › |
| 260 | KLRS Kalaris Therapeutics, Inc. | 89,3 Mio. $ Small Cap | 3,47 $ | — | — | 55 | Details › |
| 261 | ALDX Aldeyra Therapeutics, Inc. | 89,0 Mio. $ Small Cap | 1,50 $ | — | — | 60 | Details › |
| 262 | RNXT RenovoRx, Inc. | 87,5 Mio. $ Small Cap | 2,00 $ | — | — | 32 | Details › |
| 263 | FBIO Fortress Biotech, Inc. | 85,3 Mio. $ Small Cap | 2,63 $ | — | — | 49 | Details › |
| 264 | BCAB BioAtla, Inc. | 82,5 Mio. $ Small Cap | 1,26 $ | — | — | — | Details › |
| 265 | FBLG FibroBiologics, Inc. | 80,8 Mio. $ Small Cap | 1,76 $ | — | — | 20 | Details › |
| 266 | MNOV MEDICINOVA INC | 80,2 Mio. $ Small Cap | 1,79 $ | — | — | — | Details › |
| 267 | SPRB SPRUCE BIOSCIENCES, INC. | 79,5 Mio. $ Small Cap | 55,74 $ | — | — | 34 | Details › |
| 268 | GANX Gain Therapeutics, Inc. | 75,7 Mio. $ Small Cap | 1,72 $ | — | — | 45 | Details › |
| 269 | RFL Rafael Holdings, Inc. | 75,3 Mio. $ Small Cap | 2,29 $ | — | — | 50 | Details › |
| 270 | CRDF Cardiff Oncology, Inc. | 74,5 Mio. $ Small Cap | 1,05 $ | — | — | 39 | Details › |
| 271 | IBIO iBio, Inc. | 73,0 Mio. $ Small Cap | 1,26 $ | — | — | 43 | Details › |
| 272 | NTRB NutriBand Inc. | 72,6 Mio. $ Small Cap | 5,80 $ | — | — | 24 | Details › |
| 273 | ATRA Atara Biotherapeutics, Inc. | 71,5 Mio. $ Small Cap | 9,91 $ | 4,0 | — | 47 | Details › |
| 274 | PLRX PLIANT THERAPEUTICS, INC. | 71,3 Mio. $ Small Cap | 1,15 $ | — | — | 62 | Details › |
| 275 | LONA LeonaBio, Inc. | 70,6 Mio. $ Small Cap | 7,04 $ | — | — | — | Details › |
| 276 | CSBR CHAMPIONS ONCOLOGY, INC. | 69,2 Mio. $ Small Cap | 4,98 $ | — | — | — | Details › |
| 277 | BIAF bioAffinity Technologies, Inc. | 68,7 Mio. $ Small Cap | 10,50 $ | — | — | 41 | Details › |
| 278 | BSEM BioStem Technologies, Inc. | 68,6 Mio. $ Small Cap | 4,21 $ | — | — | — | Details › |
| 279 | DWTX Dogwood Therapeutics, Inc. | 68,1 Mio. $ Small Cap | 1,94 $ | — | — | 22 | Details › |
| 280 | XBIT XBiotech Inc. | 67,1 Mio. $ Small Cap | 2,18 $ | — | — | — | Details › |
| 281 | OSTX OS Therapies Inc | 66,2 Mio. $ Small Cap | 1,88 $ | — | — | 38 | Details › |
| 282 | INMB Inmune Bio, Inc. | 64,9 Mio. $ Small Cap | 2,46 $ | — | — | 61 | Details › |
| 283 | HRTX HERON THERAPEUTICS, INC. /DE/ | 64,8 Mio. $ Small Cap | 0,33 $ | — | — | 31 | Details › |
| 284 | BOLD Boundless Bio, Inc. | 64,3 Mio. $ Small Cap | 2,85 $ | — | — | 50 | Details › |
| 285 | TLSA Tiziana Life Sciences Ltd | 63,1 Mio. $ Small Cap | 0,98 $ | — | — | — | Details › |
| 286 | HYFT MindWalk Holdings Corp. | 60,6 Mio. $ Small Cap | 1,29 $ | — | — | 41 | Details › |
| 287 | OKYO OKYO Pharma Ltd | 56,0 Mio. $ Small Cap | 1,57 $ | — | — | — | Details › |
| 288 | MCRB Seres Therapeutics, Inc. | 54,7 Mio. $ Small Cap | 5,28 $ | 8,7 | — | 65 | Details › |
| 289 | APLM Apollomics Inc. | 52,9 Mio. $ Small Cap | 24,88 $ | — | — | 24 | Details › |
| 290 | IBO IMPACT BIOMEDICAL INC. | 52,3 Mio. $ Small Cap | 0,49 $ | — | — | — | Details › |
| 291 | TIL Instil Bio, Inc. | 51,4 Mio. $ Small Cap | 7,58 $ | — | — | — | Details › |
| 292 | MAIA MAIA Biotechnology, Inc. | 51,0 Mio. $ Small Cap | 1,33 $ | — | — | 60 | Details › |
| 293 | TCRX TScan Therapeutics, Inc. | 50,8 Mio. $ Small Cap | 0,33 $ | — | — | 14 | Details › |
| 294 | CELU Celularity Inc | 48,4 Mio. $ Micro Cap | 1,44 $ | — | — | 27 | Details › |
| 295 | HOWL Werewolf Therapeutics, Inc. | 47,0 Mio. $ Micro Cap | 0,97 $ | — | — | 39 | Details › |
| 296 | INKT MiNK Therapeutics, Inc. | 46,1 Mio. $ Micro Cap | 11,90 $ | — | — | — | Details › |
| 297 | SAVA FILANA THERAPEUTICS, INC. | 45,3 Mio. $ Micro Cap | 0,94 $ | — | — | — | Details › |
| 298 | MGX Metagenomi Therapeutics, Inc. | 44,0 Mio. $ Micro Cap | 1,15 $ | — | — | 43 | Details › |
| 299 | AGPU Axe Compute Inc. | 43,6 Mio. $ Micro Cap | 10,92 $ | — | — | 20 | Details › |
| 300 | ELTX Elicio Therapeutics, Inc. | 42,9 Mio. $ Micro Cap | 2,18 $ | — | — | 41 | Details › |
| 301 | GOSS Gossamer Bio, Inc. | 41,0 Mio. $ Micro Cap | 0,16 $ | — | — | 18 | Details › |
| 302 | XLO Xilio Therapeutics, Inc. | 40,8 Mio. $ Micro Cap | 8,97 $ | — | — | — | Details › |
| 303 | VERU VERU INC. | 38,7 Mio. $ Micro Cap | 2,48 $ | — | 8,1 % | 62 | Details › |
| 304 | ALGS Aligos Therapeutics, Inc. | 38,4 Mio. $ Micro Cap | 5,50 $ | — | — | 24 | Details › |
| 305 | ANVS Annovis Bio, Inc. | 37,8 Mio. $ Micro Cap | 1,22 $ | — | — | 45 | Details › |
| 306 | CING Cingulate Inc. | 37,0 Mio. $ Micro Cap | 5,21 $ | — | — | 40 | Details › |
| 307 | ACTU ACTUATE THERAPEUTICS, INC. | 34,4 Mio. $ Micro Cap | 1,27 $ | — | — | 34 | Details › |
| 308 | ERNA Ernexa Therapeutics Inc. | 33,9 Mio. $ Micro Cap | 4,02 $ | — | — | 25 | Details › |
| 309 | CALC CalciMedica, Inc. | 33,5 Mio. $ Micro Cap | 2,30 $ | — | — | 10 | Details › |
| 310 | SILO Silo Pharma, Inc. | 32,0 Mio. $ Micro Cap | 2,15 $ | — | — | — | Details › |
| 311 | BHST BIOHARVEST SCIENCES INC. | 31,6 Mio. $ Micro Cap | 1,80 $ | — | — | — | Details › |
| 312 | SER Serina Therapeutics, Inc. | 29,4 Mio. $ Micro Cap | 2,57 $ | — | — | — | Details › |
| 313 | TAOX TAO Synergies Inc. | 29,0 Mio. $ Micro Cap | 4,03 $ | — | — | 61 | Details › |
| 314 | NXTC NextCure, Inc. | 27,4 Mio. $ Micro Cap | 8,07 $ | — | — | 29 | Details › |
| 315 | PMN ProMIS Neurosciences Inc. | 27,1 Mio. $ Micro Cap | 14,37 $ | — | — | 51 | Details › |
| 316 | BYSI BeyondSpring Inc. | 25,4 Mio. $ Micro Cap | 0,63 $ | — | — | — | Details › |
| 317 | CRVO CervoMed Inc. | 23,7 Mio. $ Micro Cap | 2,51 $ | — | — | 50 | Details › |
| 318 | ALLR Allarity Therapeutics, Inc. | 22,8 Mio. $ Micro Cap | 1,26 $ | — | — | — | Details › |
| 319 | ATOS ATOSSA THERAPEUTICS, INC. | 21,7 Mio. $ Micro Cap | 2,40 $ | — | — | 36 | Details › |
| 320 | LTRN Lantern Pharma Inc. | 21,5 Mio. $ Micro Cap | 1,77 $ | — | — | 49 | Details › |
| 321 | EVAX Evaxion A/S | 20,8 Mio. $ Micro Cap | 3,29 $ | — | — | — | Details › |
| 322 | QNTM Quantum Biopharma Ltd. | 20,5 Mio. $ Micro Cap | 3,58 $ | — | — | 35 | Details › |
| 323 | JSPR Jasper Therapeutics, Inc. | 19,8 Mio. $ Micro Cap | 0,70 $ | — | — | 2 | Details › |
| 324 | MRKR Marker Therapeutics, Inc. | 19,7 Mio. $ Micro Cap | 1,21 $ | — | — | — | Details › |
| 325 | KZIA KAZIA THERAPEUTICS LTD | 19,6 Mio. $ Micro Cap | 11,88 $ | — | — | 37 | Details › |
| 326 | GNTA Genenta Science S.p.A. | 19,0 Mio. $ Micro Cap | 1,30 $ | — | — | — | Details › |
| 327 | DYAI DYADIC INTERNATIONAL INC | 18,8 Mio. $ Micro Cap | 0,51 $ | — | — | — | Details › |
| 328 | TVRD Tvardi Therapeutics, Inc. | 17,9 Mio. $ Micro Cap | 1,85 $ | — | — | — | Details › |
| 329 | ENLV Enlivex Ltd. | 17,5 Mio. $ Micro Cap | 1,04 $ | — | — | — | Details › |
| 330 | CRIS CURIS INC | 17,5 Mio. $ Micro Cap | 1,20 $ | — | — | 16 | Details › |
| 331 | COCP Cocrystal Pharma, Inc. | 15,6 Mio. $ Micro Cap | 1,24 $ | — | — | — | Details › |
| 332 | LPCN Lipocine Inc. | 15,1 Mio. $ Micro Cap | 2,25 $ | — | — | — | Details › |
| 333 | BIVI BIOVIE INC. | 15,1 Mio. $ Micro Cap | 1,97 $ | — | — | 27 | Details › |
| 334 | NRSN NeuroSense Therapeutics Ltd. | 14,8 Mio. $ Micro Cap | 0,38 $ | — | — | — | Details › |
| 335 | PASG Passage BIO, Inc. | 14,8 Mio. $ Micro Cap | 4,94 $ | — | — | — | Details › |
| 336 | LSTA LISATA THERAPEUTICS, INC. | 14,6 Mio. $ Micro Cap | 1,90 $ | — | — | 35 | Details › |
| 337 | KALA KALA BIO, Inc. | 14,1 Mio. $ Micro Cap | 0,56 $ | — | — | — | Details › |
| 338 | GRDX GridAI Technologies Corp. | 13,7 Mio. $ Micro Cap | 3,02 $ | — | — | 24 | Details › |
| 339 | KTTA Pasithea Therapeutics Corp. | 13,4 Mio. $ Micro Cap | 0,57 $ | — | — | 35 | Details › |
| 340 | CVM CEL SCI CORP | 13,1 Mio. $ Micro Cap | 1,54 $ | — | — | 42 | Details › |
| 341 | PLRZ Polyrizon Ltd. | 12,6 Mio. $ Micro Cap | 11,45 $ | — | — | — | Details › |
| 342 | ARTL ARTELO BIOSCIENCES, INC. | 12,2 Mio. $ Micro Cap | 5,98 $ | — | — | 40 | Details › |
| 343 | PDSB PDS Biotechnology Corp | 12,1 Mio. $ Micro Cap | 0,29 $ | — | — | 36 | Details › |
| 344 | MSLE Satellos Bioscience Inc. | 11,9 Mio. $ Micro Cap | 10,02 $ | — | — | 41 | Details › |
| 345 | INAB IN8BIO, INC. | 11,7 Mio. $ Micro Cap | 1,08 $ | — | — | — | Details › |
| 346 | GNPX Genprex, Inc. | 11,5 Mio. $ Micro Cap | 3,43 $ | — | — | 35 | Details › |
| 347 | XBIO Xenetic Biosciences, Inc. | 10,7 Mio. $ Micro Cap | 4,22 $ | — | — | 46 | Details › |
| 348 | DARE Dare Bioscience, Inc. | 10,5 Mio. $ Micro Cap | 0,72 $ | — | — | 29 | Details › |
| 349 | INTS INTENSITY THERAPEUTICS, INC. | 10,4 Mio. $ Micro Cap | 4,02 $ | — | — | — | Details › |
| 350 | SNTI Senti Biosciences Holdings, Inc. | 10,3 Mio. $ Micro Cap | 0,30 $ | — | — | — | Details › |
| 351 | CLDI Calidi Biotherapeutics, Inc. | 10,0 Mio. $ Micro Cap | 1,36 $ | — | — | — | Details › |
| 352 | VTGN Vistagen Therapeutics, Inc. | 9,2 Mio. $ Micro Cap | 0,24 $ | — | — | 26 | Details › |
| 353 | TOVX Theriva Biologics, Inc. | 9,0 Mio. $ Micro Cap | 0,25 $ | — | — | 38 | Details › |
| 354 | NCNA NuCana plc | 8,6 Mio. $ Micro Cap | 1,40 $ | — | — | — | Details › |
| 355 | XCUR EXICURE, INC. | 8,0 Mio. $ Micro Cap | 1,43 $ | — | — | — | Details › |
| 356 | LITS Lite Strategy, Inc. | 7,6 Mio. $ Micro Cap | 1,06 $ | — | 165,1 % | 39 | Details › |
| 357 | BOLT Bolt Biotherapeutics, Inc. | 7,5 Mio. $ Micro Cap | 3,68 $ | — | — | — | Details › |
| 358 | NEUP Neuphoria Therapeutics Inc. | 7,5 Mio. $ Micro Cap | 3,75 $ | — | — | 44 | Details › |
| 359 | OSRH OSR Health, Inc. | 7,3 Mio. $ Micro Cap | 0,28 $ | — | — | 4 | Details › |
| 360 | ALZN Alzamend Neuro, Inc. | 7,1 Mio. $ Micro Cap | 1,68 $ | — | — | 37 | Details › |
| 361 | BCTX BriaCell Therapeutics Corp. | 6,7 Mio. $ Micro Cap | 3,63 $ | — | — | 37 | Details › |
| 362 | APRE Aprea Therapeutics, Inc. | 6,5 Mio. $ Micro Cap | 0,79 $ | — | — | 49 | Details › |
| 363 | INBS INTELLIGENT BIO SOLUTIONS INC. | 6,5 Mio. $ Micro Cap | 2,24 $ | — | — | 18 | Details › |
| 364 | HCWB HCW Biologics Inc. | 6,2 Mio. $ Micro Cap | 2,46 $ | — | — | 4 | Details › |
| 365 | GTBP GT Biopharma, Inc. | 6,2 Mio. $ Micro Cap | 5,98 $ | — | — | 28 | Details › |
| 366 | SBFM Sunshine Biopharma Inc. | 5,6 Mio. $ Micro Cap | 1,12 $ | — | — | 30 | Details › |
| 367 | IMNN Imunon, Inc. | 5,4 Mio. $ Micro Cap | 1,51 $ | — | — | — | Details › |
| 368 | PCSA Processa Pharmaceuticals, Inc. | 5,3 Mio. $ Micro Cap | 1,99 $ | — | — | — | Details › |
| 369 | APM Niki BioSolutions, Inc. | 5,2 Mio. $ Micro Cap | 6,86 $ | — | — | 17 | Details › |
| 370 | MLEC Moolec Science SA | 5,0 Mio. $ Micro Cap | 6,93 $ | — | — | — | Details › |
| 371 | CLGN CollPlant Biotechnologies Ltd | 4,4 Mio. $ Micro Cap | 3,41 $ | — | — | — | Details › |
| 372 | ADXN Addex Therapeutics Ltd. | 4,4 Mio. $ Micro Cap | 3,61 $ | — | — | 34 | Details › |
| 373 | MDCX Medicus Pharma Ltd. | 4,3 Mio. $ Micro Cap | 0,17 $ | — | — | 22 | Details › |
| 374 | CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | 4,1 Mio. $ Micro Cap | 1,04 $ | — | — | 29 | Details › |
| 375 | MTVA MetaVia Inc. | 4,0 Mio. $ Micro Cap | 1,78 $ | — | — | — | Details › |
| 376 | GLMD Galmed Pharmaceuticals Ltd. | 4,0 Mio. $ Micro Cap | 3,88 $ | — | — | — | Details › |
| 377 | DCOY Decoy Therapeutics Inc. | 3,9 Mio. $ Micro Cap | 2,76 $ | — | — | — | Details › |
| 378 | SNGX SOLIGENIX, INC. | 3,8 Mio. $ Micro Cap | 0,38 $ | — | — | — | Details › |
| 379 | DRMA Dermata Therapeutics, Inc. | 3,2 Mio. $ Micro Cap | 1,21 $ | — | — | 58 | Details › |
| 380 | CANF Can-Fite BioPharma Ltd. | 2,9 Mio. $ Micro Cap | 3,32 $ | — | — | — | Details › |
| 381 | INM InMed Pharmaceuticals Inc. | 2,8 Mio. $ Micro Cap | 1,31 $ | — | — | 33 | Details › |
| 382 | MBRX Moleculin Biotech, Inc. | 2,3 Mio. $ Micro Cap | 0,77 $ | — | — | 25 | Details › |
| 383 | AZTR Azitra, Inc. | 1,9 Mio. $ Micro Cap | 0,18 $ | — | — | 48 | Details › |
| 384 | RNAZ Transcode Therapeutics, Inc. | 1,9 Mio. $ Micro Cap | 1,78 $ | — | — | 35 | Details › |
| 385 | APVO Aptevo Therapeutics Inc. | 1,7 Mio. $ Micro Cap | 1,85 $ | — | — | 28 | Details › |
| 386 | STKH Steakholder Foods Ltd. | 1,6 Mio. $ Micro Cap | 2,34 $ | — | — | — | Details › |
| 387 | GRI GRI Bio, Inc. | 1,4 Mio. $ Micro Cap | 1,80 $ | — | — | 40 | Details › |
| 388 | GOVX GeoVax Labs, Inc. | 836.800 $ Micro Cap | 0,47 $ | — | — | -2 | Details › |
| 389 | VIVS VivoSim Labs, INC. | 805.255 $ Micro Cap | 0,28 $ | — | — | — | Details › |
| 390 | RKDA Arcadia Biosciences, Inc. | 648.937 $ Micro Cap | 0,48 $ | — | — | — | Details › |
| 391 | BDRX Biodexa Pharmaceuticals Plc | 593.160 $ Micro Cap | 0,81 $ | — | — | — | Details › |
| 392 | VRAX Virax Biolabs Group Ltd | 487.091 $ Micro Cap | 2,73 $ | — | — | 34 | Details › |
| 393 | CDT CDT Equity Inc. | 333.178 $ Micro Cap | 0,60 $ | — | — | 49 | Details › |
| 394 | SPRC SciSparc Ltd. | 300.763 $ Micro Cap | 6,74 $ | — | — | — | Details › |
| 395 | PPBT PURPLE BIOTECH LTD. | 249.932 $ Micro Cap | 1,84 $ | — | — | — | Details › |
| 396 | PHGE BiomX Inc. | 235.390 $ Micro Cap | 1,62 $ | 0,1 | — | 11 | Details › |
| 397 | ADTX Aditxt, Inc. | 3.004 $ Micro Cap | 0,01 $ | — | — | 5 | Details › |